Petruk, Ganna http://orcid.org/0000-0003-1336-2900
Puthia, Manoj http://orcid.org/0000-0001-6048-7234
Samsudin, Firdaus
Petrlova, Jitka http://orcid.org/0000-0002-7554-3945
Olm, Franziska http://orcid.org/0000-0001-5222-6130
Mittendorfer, Margareta
Hyllén, Snejana http://orcid.org/0000-0003-1253-4969
Edström, Dag
Strömdahl, Ann-Charlotte
Diehl, Carl
Ekström, Simon http://orcid.org/0000-0002-7694-285X
Walse, Björn http://orcid.org/0000-0003-1513-9040
Kjellström, Sven http://orcid.org/0000-0003-4646-5279
Bond, Peter J. http://orcid.org/0000-0003-2900-098X
Lindstedt, Sandra
Schmidtchen, Artur http://orcid.org/0000-0001-9209-3141
Funding for this research was provided by:
Stiftelsen Lars Hiertas Minne
Vetenskapsrådet
Crafoordska Stiftelsen
VINNOVA
Article History
Received: 29 March 2023
Accepted: 14 September 2023
First Online: 29 September 2023
Change Date: 13 October 2023
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1038/s41467-023-42294-3
Competing interests
: The authors declare the following competing interests: A.S. is a founder of in2cure AB, a parent company of Xinnate AB, companies that are developing therapies based on thrombin-derived peptides and variants. G.P. is employed part-time (20%) by Xinnate AB. The TCP family, including stapled variants, is patent protected. Patent applicant: In2cure AB, Sweden. Inventors: Ganna Petruk, Artur Schmidtchen. Status of application: Publication Number: WO/2023/067167, Publication Date: 27.04.2023, International Application No.: PCT/EP2022/079429, International Filing Date: 21.10.2022. Specific aspect of manuscript covered in patent application: The invention relates to thrombin derived peptides comprising at least one internal covalent linkage between the side chains of two non-neighboring, internal amino acids. The peptides have anti-inflammatory effect. The sequences described herein are included in the patent application. The other authors declare no financial or non-financial conflicts of interest.